|
1
|
Kopp F and Mendell JT: Functional
classification and experimental dissection of long noncoding RNAs.
Cell. 172:393–407. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Schmitz SU, Grote P and Herrmann BG:
Mechanisms of long noncoding RNA function in development and
disease. Cell Mol Life Sci. 73:2491–2509. 2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Zhou Y, Zhang X and Klibanski A: MEG3
noncoding RNA: A tumor suppressor. J Mol Endocrinol. 48:R45–R53.
2012.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Yan J, Guo X, Xia J, Shan T, Gu C, Liang
Z, Zhao W and Jin S: MiR-148a regulates MEG3 in gastric cancer by
targeting DNA methyltransferase 1. Med Oncol.
31(879)2014.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Zhao J, Zhang X, Zhou Y, Ansell PJ and
Klibanski A: Cyclic AMP stimulates MEG3 gene expression in cells
through a cAMP-response element (CRE) in the MEG3 proximal promoter
region. Int J Biochem Cell Biol. 38:1808–1820. 2006.PubMed/NCBI View Article : Google Scholar
|
|
7
|
He C, Yang W and Yang J, Ding J, Li S, Wu
H, Zhou F, Jiang Y, Teng L and Yang J: Long noncoding RNA MEG3
negatively regulates proliferation and angiogenesis in vascular
endothelial cells. DNA Cell Biol. 36:475–481. 2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Chunharojrith P, Nakayama Y, Jiang X, Kery
RE, Ma J, De La Hoz Ulloa CS, Zhang X, Zhou Y and Klibanski A:
Tumor suppression by MEG3 lncRNA in a human pituitary tumor derived
cell line. Mol Cell Endocrinol. 416:27–35. 2015.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Zhang X, Zhou Y, Mehta KR, Danila DC,
Scolavino S, Johnson SR and Klibanski A: A pituitary-derived MEG3
isoform functions as a growth suppressor in tumor cells. J Clin
Endocrinol Metab. 88:5119–5126. 2003.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Zhuang W, Ge X, Yang S, Huang M, Zhuang W,
Chen P, Zhang X, Fu J, Qu J and Li B: Upregulation of lncRNA MEG3
promotes osteogenic differentiation of mesenchymal stem cells from
multiple myeloma patients by targeting BMP4 transcription. Stem
Cells. 33:1985–1997. 2015.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Liu Y, Zeng X, Miao J, Liu C, Wei F, Liu
D, Zheng Z, Ting K, Wang C and Guo J: Upregulation of long
noncoding RNA MEG3 inhibits the osteogenic differentiation of
periodontal ligament cells. J Cell Physiol. 234:4617–4626.
2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Jiang M, Wang YR, Xu N, Zhou L and An Q:
Long noncoding RNA MEG3 play an important role in osteosarcoma
development through sponging microRNAs. J Cell Biochem.
120:5151–5159. 2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Chen K, Zhu H, Zheng MQ and Dong QR:
LncRNA MEG3 inhibits the degradation of the extracellular matrix of
chondrocytes in osteoarthritis via targeting miR-93/TGFBR2 axis.
Cartilage: Jun 28, 2019 (Epub ahead of print).
|
|
14
|
Wang Q, Li Y and Zhang Y, Ma L, Lin L,
Meng J, Jiang L, Wang L, Zhou P and Zhang Y: LncRNA MEG3 inhibited
osteogenic differentiation of bone marrow mesenchymal stem cells
from postmenopausal osteoporosis by targeting miR-133a-3p. Biomed
Pharmacother. 89:1178–1186. 2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Liu YR, Yang L, Xu QQ, Lu XY, Ma TT, Huang
C and Li J: Long noncoding RNA MEG3 regulates rheumatoid arthritis
by targeting NLRC5. J Cell Physiol. 234:14270–14284.
2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Huang G, Kang Y, Huang Z and Zhang Z, Meng
F, Chen W, Fu M, Liao W and Zhang Z: Identification and
characterization of long non-coding RNAs in osteogenic
differentiation of human adipose-derived stem cells. Cell Physiol
Biochem. 42:1037–1050. 2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Long Y, Wang X, Youmans DT and Cech TR:
How do lncRNAs regulate transcription? Sci Adv.
3(eaao2110)2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Zhang X, Guo J, Zhou Y and Wu G: The roles
of bone morphogenetic proteins and their signaling in the
osteogenesis of adipose-derived stem cells. Tissue Eng Part B Rev.
20:84–92. 2014.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Deng L, Hong H, Zhang X, Chen D, Chen Z,
Ling J and Wu L: Down-regulated lncRNA MEG3 promotes osteogenic
differentiation of human dental follicle stem cells by
epigenetically regulating Wnt pathway. Biochem Biophys Res Commun.
503:2061–2067. 2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Stephens KE, Miaskowski CA, Levine JD,
Pullinger CR and Aouizerat BE: Epigenetic regulation and
measurement of epigenetic changes. Biol Res Nurs. 15:373–381.
2013.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Dykes IM and Emanueli C: Transcriptional
and post-transcriptional gene regulation by long non-coding RNA.
Genomics Proteomics Bioinformatics. 15:177–186. 2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Filipowicz W, Bhattacharyya SN and
Sonenberg N: Mechanisms of post-transcriptional regulation by
microRNAs: Are the answers in sight? Nat Rev Genet. 9:102–114.
2008.PubMed/NCBI View
Article : Google Scholar
|
|
23
|
Xue M, Zhuo Y and Shan B: MicroRNAs, long
noncoding RNAs, and their functions in human disease. Methods Mol
Biol. 1617:1–25. 2017.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Yoon JH, Abdelmohsen K and Gorospe M:
Functional interactions among microRNAs and long noncoding RNAs.
Semin Cell Dev Biol. 34:9–14. 2014.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Paraskevopoulou MD and Hatzigeorgiou AG:
Analyzing miRNA-lncRNA interactions. Methods Mol Biol.
1402:271–286. 2016.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Li Z, Jin C, Chen S, Zheng Y, Huang Y, Jia
L, Ge W and Zhou Y: Long non-coding RNA MEG3 inhibits adipogenesis
and promotes osteogenesis of human adipose-derived mesenchymal stem
cells via miR-140-5p. Mol Cell Biochem. 433:51–60. 2017.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Yang Z, Li X, Yang Y, He Z, Qu X and Zhang
Y: Long noncoding RNAs in the progression, metastasis, and
prognosis of osteosarcoma. Cell Death Dis. 7(e2389)2016.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Fu M, Huang G, Zhang Z, Liu J, Zhang Z,
Huang Z, Yu B and Meng F: Expression profile of long noncoding RNAs
in cartilage from knee osteoarthritis patients. Osteoarthritis
Cartilage. 23:423–432. 2015.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Sun H, Peng G, Ning X, Wang J, Yang H and
Deng J: Emerging roles of long noncoding RNA in chondrogenesis,
osteogenesis, and osteoarthritis. Am J Transl Res. 11:16–30.
2019.PubMed/NCBI
|
|
30
|
Silva AM, Moura SR, Teixeira JH, Barbosa
MA, Santos SG and Almeida MI: Long noncoding RNAs: A missing link
in osteoporosis. Bone Res. 7(10)2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Wu QY, Li X, Miao ZN, Ye JX, Wang B, Zhang
F, Xu RS, Jiang DL, Zhao MD and Yuan FL: Long non-coding RNAs: A
new regulatory code for osteoporosis. Front Endocrinol (Lausanne).
9(587)2018.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Li Z, Li X, Jiang C, Qian W, Tse G, Chan
MTV and Wu WKK: Long non-coding RNAs in rheumatoid arthritis. Cell
Prolif 51, 2018.
|
|
33
|
Xu Z, Zhou X, Li H, Chen Q and Chen G:
Identification of the key genes and long non-coding RNAs in
ankylosing spondylitis using RNA sequencing. Int J Mol Med.
43:1179–1192. 2019.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Geller DS and Gorlick R: Osteosarcoma: A
review of diagnosis, management, and treatment strategies. Clin Adv
Hematol Oncol. 8:705–718. 2010.PubMed/NCBI
|
|
35
|
Mirabello L, Troisi RJ and Savage SA:
Osteosarcoma incidence and survival rates from 1973 to 2004: Data
from the surveillance, epidemiology, and end results program.
Cancer. 115:1531–1543. 2009.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Ren K, Ni Y, Li X, Wang C, Chang Q, Li Y,
Gao Z, Wu S, Shi X, Song J, et al: Expression profiling of long
noncoding RNAs associated with vasculogenic mimicry in
osteosarcoma. J Cell Biochem. 120:12473–12488. 2019.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Zhang S, Ding L, Li X and Fan H:
Identification of biomarkers associated with the recurrence of
osteosarcoma using ceRNA regulatory network analysis. Int J Mol
Med. 43:1723–1733. 2019.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Al-Rugeebah A, Alanazi M and Parine NR:
MEG3: An oncogenic long non-coding RNA in different cancers. Pathol
Oncol Res. 25:859–874. 2019.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Shi Y, Lv C, Shi L and Tu G: MEG3 inhibits
proliferation and invasion and promotes apoptosis of human
osteosarcoma cells. Oncol Lett. 15:1917–1923. 2018.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Zhang SZ, Cai L and Li B: MEG3 long
non-coding RNA prevents cell growth and metastasis of osteosarcoma.
Bratisl Lek Listy. 118:632–636. 2017.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Tian ZZ, Guo XJ, Zhao YM and Fang Y:
Decreased expression of long non-coding RNA MEG3 acts as a
potential predictor biomarker in progression and poor prognosis of
osteosarcoma. Int J Clin Exp Pathol. 8:15138–15142. 2015.PubMed/NCBI
|
|
42
|
Sun L, Yang C, Xu J, Feng Y, Wang L and
Cui T: Long noncoding RNA EWSAT1 promotes osteosarcoma cell growth
and metastasis through suppression of MEG3 Expression. DNA Cell
Biol. 35:812–818. 2016.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Sahin Y, Altan Z, Arman K, Bozgeyik E,
Koruk OM and Arslan A: Inhibition of miR-664a interferes with the
migration of osteosarcoma cells via modulation of MEG3. Biochem
Biophys Res Commun. 490:1100–1105. 2017.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Shen B, Zhou N, Hu T, Zhao W, Wu D and
Wang S: LncRNA MEG3 negatively modified osteosarcoma development
through regulation of miR-361-5p and FoxM1. J Cell Physiol.
234:13464–13480. 2019.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Wang Y and Kong D: Knockdown of lncRNA
MEG3 inhibits viability, migration, and invasion and promotes
apoptosis by sponging miR-127 in osteosarcoma cell. J Cell Biochem.
119:669–679. 2018.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Marino S and Roodman GD: Multiple myeloma
and bone: The fatal interaction. Cold Spring Harb Perspect Med. 8:
pii(a031286)2018.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Terpos E, Politou M and Rahemtulla A: The
role of markers of bone remodeling in multiple myeloma. Blood Rev.
19:125–142. 2005.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Benetatos L, Dasoula A, Hatzimichael E,
Georgiou I, Syrrou M and Bourantas KL: Promoter hypermethylation of
the MEG3 (DLK1/MEG3) imprinted gene in multiple myeloma. Clin
Lymphoma Myeloma. 8:171–175. 2008.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Shen X, Bai H, Zhu H, Yan Q, Yang Y, Yu W,
Shi Q, Wang J, Li J and Chen L: Long non-coding RNA MEG3 functions
as a competing endogenous RNA to regulate HOXA11 expression by
sponging miR-181a in multiple myeloma. Cell Physiol Biochem.
49:87–100. 2018.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Wang M, Shen J, Jin H, Im HJ, Sandy J and
Chen D: Recent progress in understanding molecular mechanisms of
cartilage degeneration during osteoarthritis. Ann N Y Acad Sci.
1240:61–69. 2011.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Pearson MJ, Philp AM, Heward JA, Roux BT,
Walsh DA, Davis ET, Lindsay MA and Jones SW: Long intergenic
noncoding RNAs mediate the human chondrocyte inflammatory response
and are differentially expressed in osteoarthritis cartilage.
Arthritis Rheumatol. 68:845–856. 2016.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Xing D, Liang JQ, Li Y, Lu J, Jia HB, Xu
LY and Ma XL: Identification of long noncoding RNA associated with
osteoarthritis in humans. Orthop Surg. 6:288–293. 2014.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Su W, Xie W, Shang Q and Su B: The long
noncoding RNA MEG3 is downregulated and inversely associated with
VEGF levels in osteoarthritis. Biomed Res Int.
2015(356893)2015.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Ashraf S and Walsh DA: Angiogenesis in
osteoarthritis. Curr Opin Rheumatol. 20:573–580. 2008.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Wang Z, Chi X, Liu L, Wang Y, Mei X, Yang
Y and Jia T: Long noncoding RNA maternally expressed gene 3
knockdown alleviates lipopolysaccharide-induced inflammatory injury
by up-regulation of miR-203 in ATDC5 cells. Biomed Pharmacother.
100:240–249. 2018.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Xu J and Xu Y: The lncRNA MEG3
downregulation leads to osteoarthritis progression via miR-16/SMAD7
axis. Cell Biosci. 7(69)2017.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Zheng J and Li Q: Methylene blue regulates
inflammatory response in osteoarthritis by noncoding long chain RNA
CILinc02. J Cell Biochem. 120:3331–3338. 2019.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Li X, Tang C, Wang J, Guo P, Wang C, Wang
Y, Zhang Z and Wu H: Methylene blue relieves the development of
osteoarthritis by upregulating lncRNA MEG3. Exp Ther Med.
15:3856–3864. 2018.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Tu KN, Lie JD, Wan CKV, Cameron M, Austel
AG, Nguyen JK, Van K and Hyun D: Osteoporosis: A review of
treatment options. P T. 43:92–104. 2018.PubMed/NCBI
|
|
60
|
Riggs BL: The mechanisms of estrogen
regulation of bone resorption. J Clin Invest. 106:1203–1204.
2000.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Raisz LG: Pathogenesis of osteoporosis:
Concepts, conflicts, and prospects. J Clin Invest. 115:3318–3325.
2005.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Fei Q, Bai X, Lin J, Meng H, Yang Y and
Guo A: Identification of aberrantly expressed long non-coding RNAs
in postmenopausal osteoporosis. Int J Mol Med. 41:3537–3550.
2018.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Chen S, Jia L, Zhang S, Zheng Y and Zhou
Y: DEPTOR regulates osteogenic differentiation via inhibiting
MEG3-mediated activation of BMP4 signaling and is involved in
osteoporosis. Stem Cell Res Ther. 9(185)2018.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Garcia-Montoya L, Gul H and Emery P:
Recent advances in ankylosing spondylitis: Understanding the
disease and management. F1000Res 7 (F1000 Faculty Rev): 1512,
2018.
|
|
65
|
Aletaha D and Smolen JS: Diagnosis and
management of rheumatoid arthritis: A Review. JAMA. 320:1360–1372.
2018.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Liu W, Huang L, Zhang C and Liu Z: lncRNA
MEG3 is downregulated in ankylosing spondylitis and associated with
disease activity, hospitalization time and disease duration. Exp
Ther Med. 17:291–297. 2019.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Liu YR, Yan X and Yu HX: NLRC5 promotes
cell proliferation via regulating the NF-κB signaling pathway in
Rheumatoid arthritis. Mol Immunol. 91:24–34. 2017.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Lu X and Qian J: Downregulated MEG3
participates in rheumatoid arthritis via promoting proliferation of
fibroblast-like synoviocytes. Exp Ther Med. 17:1637–1642.
2019.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Liu YB, Lin LP, Zou R, Zhao QH and Lin FQ:
Silencing long non-coding RNA MEG3 accelerates tibia fraction
healing by regulating the Wnt/β-catenin signalling pathway. J Cell
Mol Med. 23:3855–3866. 2019.PubMed/NCBI View Article : Google Scholar
|
